FDA approves OSPREY study to evaluate aura6000 System to treat OSA
LivaNova has received approval from the FDA to proceed with its investigational device exemption (IDE) clinical study, ‘Treating...
top of page
Browse by category
Search
Browse by tag
bottom of page